GSK vs VVV · P/E 13, $103.31B cap vs P/E 51, rev $1.71B
GlaxoSmithKline PLC ADR (GSK) versus Valvoline Inc (VVV) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Valvoline Inc (VVV) is a auto & truck dealerships company listed on NYSE.
GSK does not have a complete income-statement cache yet.
Latest reported VVV revenue for 2025-09-30 was $1.71B. Net income was $210.7M. VVV currently screens at market cap $4.84B and trailing P/E 50.6.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. VVV currently screens at market cap $4.84B and trailing P/E 50.6.
Not investment advice. Open the GSK and VVV stock pages for the full models.
Not investment advice.